Commercialization &
Investment Opportunities
We have developed several novel technologies that are available for commercialization.
These areas include
- Development of novel cellular therapeutics for infectious diseases
- Diagnostic tools for the identification of immune deficits in patients
- Novel small molecular anti-fungal agents
- Therapeutic programs for immune modulation of immune host responses